Sunrise expands trial of collagen-shrinking eye treatment
This article was originally published in Clinica
Executive Summary
Sunrise Technologies is to enrol an additional 100 patients in its US study of a collagen-shrinking laser treatment for far-sightedness, after receiving FDA approval to expand the trial.